|Articles|April 1, 1999

April 1999
Volume 5
Issue 4

Celecoxib: A COX-2 Inhibitor

Author(s)S. Allyson Andrews, PharmD, Christy K. Wallace, PharmD, Roger L. Davis, PharmD

Download PDF: Celecoxib: A COX-2 Inhibitor

Articles in this issue

almost 27 years ago

Article

Medicaid Recipients' Experiences Under Mandatory Managed Care

almost 27 years ago

Article

Why Primary Care Physicians Join HMOs

almost 27 years ago

Article

Discontinuation Rates of Cholesterol-Lowering Medications

almost 27 years ago

Article

The Role of Resource Allocation Models in Selecting Clinical Preventive Services

almost 27 years ago

Article

Is Prior Authorization of Topical Tretinoin for Acne Cost Effective?

almost 27 years ago

Article

Impact of Therapeutic Interchange from Pravastatin to Lovastatin in a Veterans Affairs Medical Center

almost 27 years ago

Article

Targeted Intervention Programs: Creating a Customized Practice Model to Improve the Treatment of Allergic Rhinitis in a Managed Care Population

almost 27 years ago

Article

Disease Management of Congestive Heart Failure

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Celecoxib: A COX-2 Inhibitor

Articles in this issue

Newsletter

Related Content

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps

Novel CLL Therapies Prompt New Treatment Considerations

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns